{"data":{"id":744,"citation":"Fujimori Y, Katsuno K, Nakashima I, Ishikawa-Takemura Y, Fujikura H, Isaji M.: Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models. J Pharmacol Exp Ther, Volume 327 (1), 2008","title":"Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models.","doi":"10.1124\/jpet.108.140210","doi_url":"https:\/\/doi.org\/10.1124\/jpet.108.140210","pmid":"18583547","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/18583547\/","year":2008,"journal":"J Pharmacol Exp Ther","volume":"327","issue":"1","page":"268-276","authors":[{"first_name":"Fujikura H","last_name":null,"full_name":null},{"first_name":"Fujimori Y","last_name":null,"full_name":null},{"first_name":"Isaji M.","last_name":null,"full_name":null},{"first_name":"Ishikawa-Takemura Y","last_name":null,"full_name":null},{"first_name":"Katsuno K","last_name":null,"full_name":null},{"first_name":"Nakashima I","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/744","landing_page":"https:\/\/molmedb.upol.cz\/publication\/744","created_at":"2020-08-24T06:50:44.000000Z","updated_at":null}}